Combined Diagnostic Value of Hsa-miR-592 and Hsa-miR-9-3p in Plasma for Methamphetamine Addicts

• Published in: International journal of molecular sciences Vol. 25; no. 16; p. 8952
• Main Authors: Li, Wenbo, Liu, Diandian, Liu, Xiaokun, Lu, Yun, Zhang, Ludi, Yu, Feng, Yu, Hailei, Ma, Chunling, Cong, Bin, Wen, Di, Xie, Bing
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 16.08.2024; MDPI
• Subjects: Adult; Amphetamine-Related Disorders - blood; Amphetamine-Related Disorders - diagnosis; Amphetamine-Related Disorders - genetics; BDNF; Binomial distribution; Biomarkers; Biomarkers - blood; Drug addiction; Drug withdrawal; Female; Gene expression; Gene Expression Profiling; High-Throughput Nucleotide Sequencing - methods; hsa-miR-592; hsa-miR-9-3p; Humans; Male; METH; Methamphetamine; Methamphetamine - adverse effects; MicroRNAs; MicroRNAs - blood; MicroRNAs - genetics; Plasma; ROC; ROC Curve; METH; hsa-miR-9-3p; BDNF; hsa-miR-592; ROC
• ISSN: 1661-6596; 1422-0067; 1422-0067
• DOI: 10.3390/ijms25168952

A number of studies have reported that drug addiction is associated with microRNAs (miRNAs). However, the roles of plasma miRNAs in methamphetamine (METH) addicts have not been clearly explained. This study aimed to profile a panel of miRNAs as non-invasive predictive biomarkers and therapeutic targets for METH addiction. Differentially expressed miRNAs were derived from next-generation sequencing technology (NGS) and were validated by quantitative real-time PCR (RT-qPCR). The diagnostic value of specific altered miRNAs was evaluated by receiver operating characteristic (ROC) analysis and area under the curve (AUC). NGS results revealed that 63 miRNAs were significantly altered in the METH-exposed paradigm. The levels of hsa-miR-592, hsa-miR-9-3p, hsa-miR-206 and hsa-let-7b-3p were significantly elevated in the plasma of METH addicts. Hsa-miR-9-3p was a useful biomarker discriminating METH addicts from normal (AUC was 0.756). Importantly, combining detection of hsa-miR-592 and hsa-miR-9-3p achieved the highest AUC of 0.87, with a sensitivity and specificity of 82.7% and 78.9%, respectively. Target gene BDNF decreased significantly in METH addicts. Although METH addicts showed significant depressive symptoms, there was no correlation between the expression level of miR-592 and miR-9-3p and the degree of depression. Our findings suggested that hsa-miR-592, hsa-miR-9-3p, hsa-miR-206, and hsa-let-7b-3p may play a potential role in the pathology of METH addiction, and a combination of hsa-miR-592 and hsa-miR-9-3p could serve as potential peripheral biomarker and therapeutic target for METH addiction.